Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Exp Biol ; 223(Pt 22)2020 11 20.
Artigo em Inglês | MEDLINE | ID: mdl-33037110

RESUMO

Oxidative stress, which occurs from an imbalance of reactive oxygen and nitrogen species (RONS) and both endogenous and exogenous antioxidants, promotes aging and underlies sex-specific differences in longevity and susceptibility to age-related neurodegeneration. Recent evidence suggests that curcumin, a yellow pigment derived from turmeric and shown to exhibit antioxidant properties as a RONS scavenger, influences the regulation of genetic elements in endogenous antioxidant pathways. To investigate the role of curcumin in sex-specific in vivo responses to oxidative stress, Drosophila were reared on media supplemented with 0.25, 2.5 or 25 mmol l-1 curcuminoids (consisting of curcumin, demethoxycurcumin and bisdemethoxycurcumin) and resistance to oxidative stress and neural parameters were assessed. High levels of curcuminoids exhibited two sex-specific effects: protection from hydrogen peroxide as an oxidative stressor and alterations in turning rate in an open field. Taken together, these results suggest that the influence of curcuminoids as antioxidants probably relies on changes in gene expression and that sexual dimorphism exists in the in vivo response to curcuminoids.


Assuntos
Curcumina , Animais , Antioxidantes , Curcumina/farmacologia , Drosophila melanogaster/genética , Feminino , Masculino , Estresse Oxidativo , Espécies Reativas de Oxigênio
2.
BioTech (Basel) ; 12(3)2023 Sep 08.
Artigo em Inglês | MEDLINE | ID: mdl-37754202

RESUMO

While normal levels of reactive oxygen and nitrogen species (RONS) are required for proper organismal function, increased levels result in oxidative stress. Oxidative stress may be managed via the scavenging activities of antioxidants (e.g., curcumin) and the action of enzymes, including superoxide dismutase (SOD). In this work, the uptake and clearance of dietary curcuminoids (consisting of curcumin, demethoxycurcumin, and bisdemethoxycurcumin) was assessed in Drosophila melanogaster larvae following chronic or acute exposure. High levels of curcuminoid uptake and loss were observed within a few hours and leveled off within eight hours post treatment onset. The addition or removal of curcuminoids from media resulted in corresponding changes in SOD activity, and the involvement of each of the three SOD genes was assessed for their contribution to total SOD activity. Taken together, these data provide insight into the uptake and clearance dynamics of curcuminoids and indicate that, while SOD activity generally increases following curcuminoid treatment, the individual SOD genes appear to contribute differently to this response.

3.
J Neurosci ; 31(6): 2248-57, 2011 Feb 09.
Artigo em Inglês | MEDLINE | ID: mdl-21307261

RESUMO

The vesicle protein synaptotagmin I is the Ca(2+) sensor that triggers fast, synchronous release of neurotransmitter. Specifically, Ca(2+) binding by the C(2)B domain of synaptotagmin is required at intact synapses, yet the mechanism whereby Ca(2+) binding results in vesicle fusion remains controversial. Ca(2+)-dependent interactions between synaptotagmin and SNARE (soluble N-ethylmaleimide-sensitive fusion protein attachment receptor) complexes and/or anionic membranes are possible effector interactions. However, no effector-interaction mutations to date impact synaptic transmission as severely as mutation of the C(2)B Ca(2+)-binding motif, suggesting that these interactions are facilitatory rather than essential. Here we use Drosophila to show the functional role of a highly conserved, hydrophobic residue located at the tip of each of the two Ca(2+)-binding pockets of synaptotagmin. Mutation of this residue in the C(2)A domain (F286) resulted in a ∼50% decrease in evoked transmitter release at an intact synapse, again indicative of a facilitatory role. Mutation of this hydrophobic residue in the C(2)B domain (I420), on the other hand, blocked all locomotion, was embryonic lethal even in syt I heterozygotes, and resulted in less evoked transmitter release than that in syt(null) mutants, which is more severe than the phenotype of C(2)B Ca(2+)-binding mutants. Thus, mutation of a single, C(2)B hydrophobic residue required for Ca(2+)-dependent penetration of anionic membranes results in the most severe disruption of synaptotagmin function in vivo to date. Our results provide direct support for the hypothesis that plasma membrane penetration, specifically by the C(2)B domain of synaptotagmin, is the critical effector interaction for coupling Ca(2+) binding with vesicle fusion.


Assuntos
Cálcio/metabolismo , Fusão de Membrana/fisiologia , Vesículas Sinápticas/fisiologia , Sinaptotagminas/metabolismo , Fatores Etários , Análise de Variância , Animais , Animais Geneticamente Modificados , Proteínas de Ligação ao Cálcio/genética , Proteínas de Ligação ao Cálcio/metabolismo , Drosophila , Proteínas de Drosophila/genética , Eletrofisiologia , Embrião não Mamífero , Potenciais Pós-Sinápticos Excitadores/genética , Fracionamento por Campo e Fluxo/métodos , Técnicas In Vitro , Fusão de Membrana/genética , Mutagênese Sítio-Dirigida/métodos , Proteínas do Tecido Nervoso/metabolismo , Junção Neuromuscular/fisiologia , Estrutura Terciária de Proteína/genética , Ratos , Proteínas SNARE/genética , Proteínas SNARE/metabolismo , Alinhamento de Sequência , Análise Espectral , Sinaptotagminas/química , Sinaptotagminas/genética
4.
Microbiol Resour Announc ; 9(12)2020 Mar 19.
Artigo em Inglês | MEDLINE | ID: mdl-32193232

RESUMO

Vibrio sp. strain OCN044 is a Gram-negative gammaproteobacterium found in marine environments. Presented here is the whole-draft genome sequence of nonpathogenic Vibrio sp. strain OCN044, isolated from a healthy Acropora cytherea colony off the western reef terrace of Palmyra Atoll.

5.
Microbiol Resour Announc ; 9(32)2020 Aug 06.
Artigo em Inglês | MEDLINE | ID: mdl-32763929

RESUMO

The draft genome of Streptomyces sp. strain ventii, an environmental isolate recovered from deep-sea hydrothermal vents in the Pacific Ocean, is presented along with the resequenced draft genomes of the type strains Streptomyces bohaiensis 11A07 and Streptomyces lonarensis NCL 716.

6.
J Neurosci ; 28(30): 7458-66, 2008 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-18650324

RESUMO

Synaptotagmin I is the Ca(2+) sensor for fast, synchronous release of neurotransmitter; however, the molecular interactions that couple Ca(2+) binding to membrane fusion remain unclear. The structure of synaptotagmin is dominated by two C(2) domains that interact with negatively charged membranes after binding Ca(2+). In vitro work has implicated a conserved basic residue at the tip of loop 3 of the Ca(2+)-binding pocket in both C(2) domains in coordinating this electrostatic interaction with anionic membranes. Although results from cultured cells suggest that the basic residue of the C(2)A domain is functionally significant, such studies provide contradictory results regarding the importance of the C(2)B basic residue during vesicle fusion. To directly test the functional significance of each of these residues at an intact synapse in vivo, we neutralized either the C(2)A or the C(2)B basic residue and assessed synaptic transmission at the Drosophila neuromuscular junction. The conserved basic residues at the tip of the Ca(2+)-binding pocket of both the C(2)A and C(2)B domains mediate Ca(2+)-dependent interactions with anionic membranes and are required for efficient evoked transmitter release. Our results directly support the hypothesis that the interactions between synaptotagmin and the presynaptic membrane, which are mediated by the basic residues at the tip of both the C(2)A and C(2)B Ca(2+)-binding pockets, are critical for coupling Ca(2+) influx with vesicle fusion during synaptic transmission in vivo. Our model for synaptotagmin's direct role in coupling Ca(2+) binding to vesicle fusion incorporates this finding with results from multiple in vitro and in vivo studies.


Assuntos
Proteínas de Ligação ao Cálcio/fisiologia , Cálcio/metabolismo , Potenciais Pós-Sinápticos Excitadores/fisiologia , Sinaptotagmina I/metabolismo , Aciltransferases/metabolismo , Análise de Variância , Animais , Animais Geneticamente Modificados , Arginina/genética , Proteínas de Ligação ao Cálcio/genética , Drosophila , Proteínas de Drosophila , Estimulação Elétrica/métodos , Eletrofisiologia/métodos , Embrião não Mamífero , Técnicas In Vitro , Mutagênese Sítio-Dirigida/métodos , Junção Neuromuscular/fisiologia , Ligação Proteica , Estrutura Terciária de Proteína , Sinaptotagmina I/genética
7.
Dis Model Mech ; 7(3): 373-85, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24487408

RESUMO

Alzheimer's disease (AD) is an age-related neurodegenerative disease characterized by memory loss and decreased synaptic function. Advances in transgenic animal models of AD have facilitated our understanding of this disorder, and have aided in the development, speed and efficiency of testing potential therapeutics. Recently, we have described the characterization of a novel model of AD in the fruit fly, Drosophila melanogaster, where we expressed the human AD-associated proteins APP and BACE in the central nervous system of the fly. Here we describe synaptic defects in the larval neuromuscular junction (NMJ) in this model. Our results indicate that expression of human APP and BACE at the larval NMJ leads to defective larval locomotion behavior, decreased presynaptic connections, altered mitochondrial localization in presynaptic motor neurons and decreased postsynaptic protein levels. Treating larvae expressing APP and BACE with the γ-secretase inhibitor L-685,458 suppresses the behavioral defects as well as the pre- and postsynaptic defects. We suggest that this model will be useful to assess and model the synaptic dysfunction normally associated with AD, and will also serve as a powerful in vivo tool for rapid testing of potential therapeutics for AD.


Assuntos
Doença de Alzheimer/patologia , Drosophila melanogaster/fisiologia , Sinapses/patologia , Doença de Alzheimer/metabolismo , Secretases da Proteína Precursora do Amiloide/metabolismo , Precursor de Proteína beta-Amiloide/metabolismo , Animais , Animais Geneticamente Modificados , Ácido Aspártico Endopeptidases/metabolismo , Comportamento Animal/efeitos dos fármacos , Modelos Animais de Doenças , Proteínas de Drosophila/metabolismo , Drosophila melanogaster/genética , Inibidores Enzimáticos/farmacologia , Humanos , Larva/metabolismo , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Neurônios Motores/efeitos dos fármacos , Neurônios Motores/metabolismo , Neurônios Motores/patologia , Fenótipo , Transporte Proteico/efeitos dos fármacos , Sinapses/metabolismo , Transgenes
8.
J Alzheimers Dis ; 33(1): 3-16, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-22886023

RESUMO

A majority of the genes linked to human disease belong to evolutionarily conserved pathways found in simpler organisms, such as Caenorhabditis elegans and Drosophila melanogaster. The genes and pathways of these simple organisms can be genetically and pharmacologically manipulated to better understand the function of their orthologs in vivo, and how these genes are involved in the pathogenesis of different diseases. Often these manipulations can be performed much more rapidly in flies and worms than in mammals, and can generate high quality in vivo data that is translatable to mammalian systems. Other qualities also make these organisms particularly well suited to the study of human disease. For example, developing in vivo disease models can help illuminate the basic mechanisms underlying disease, as in vitro studies do not always provide the natural physiological complexity associated with many diseases. Invertebrate models are relatively inexpensive, easy to work with, have short lifespans, and often have very well characterized and stereotypical development and behavior. This is particularly true for the two invertebrate model organisms that this review will focus on: Caenorhabditis elegans and Drosophila melanogaster. In this review, we will first describe an overview of modeling Alzheimer's disease in flies and worms, and will then highlight some of the more recent advances that these "simple" animals have contributed to our understanding of Alzheimer's disease in recent years.


Assuntos
Doença de Alzheimer/genética , Doença de Alzheimer/patologia , Caenorhabditis elegans/genética , Modelos Animais de Doenças , Drosophila melanogaster/genética , Animais , Animais Geneticamente Modificados , Humanos , Invertebrados/genética , Especificidade da Espécie
9.
PLoS One ; 6(6): e20799, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21673973

RESUMO

Transgenic models of Alzheimer's disease (AD) have made significant contributions to our understanding of AD pathogenesis, and are useful tools in the development of potential therapeutics. The fruit fly, Drosophila melanogaster, provides a genetically tractable, powerful system to study the biochemical, genetic, environmental, and behavioral aspects of complex human diseases, including AD. In an effort to model AD, we over-expressed human APP and BACE genes in the Drosophila central nervous system. Biochemical, neuroanatomical, and behavioral analyses indicate that these flies exhibit aspects of clinical AD neuropathology and symptomology. These include the generation of Aß(40) and Aß(42), the presence of amyloid aggregates, dramatic neuroanatomical changes, defects in motor reflex behavior, and defects in memory. In addition, these flies exhibit external morphological abnormalities. Treatment with a γ-secretase inhibitor suppressed these phenotypes. Further, all of these phenotypes are present within the first few days of adult fly life. Taken together these data demonstrate that this transgenic AD model can serve as a powerful tool for the identification of AD therapeutic interventions.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/fisiopatologia , Carbamatos/farmacologia , Cognição/efeitos dos fármacos , Dipeptídeos/farmacologia , Inibidores de Proteases/farmacologia , Doença de Alzheimer/metabolismo , Secretases da Proteína Precursora do Amiloide/antagonistas & inibidores , Secretases da Proteína Precursora do Amiloide/metabolismo , Precursor de Proteína beta-Amiloide/metabolismo , Animais , Comportamento Animal/efeitos dos fármacos , Comportamento Animal/fisiologia , Encéfalo/efeitos dos fármacos , Encéfalo/crescimento & desenvolvimento , Encéfalo/metabolismo , Encéfalo/fisiopatologia , Carbamatos/uso terapêutico , Cognição/fisiologia , Dipeptídeos/uso terapêutico , Modelos Animais de Doenças , Drosophila melanogaster , Avaliação Pré-Clínica de Medicamentos , Feminino , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Humanos , Masculino , Atividade Motora/efeitos dos fármacos , Atividade Motora/fisiologia , Fenótipo , Inibidores de Proteases/uso terapêutico , Reflexo/efeitos dos fármacos , Reflexo/fisiologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa